Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.
N Engl J Med. 2017 Sep 7;377(10):923-935. doi: 10.1056/NEJMoa1700228.
N Engl J Med. 2017.
PMID: 28877027
Free article.
Clinical Trial.
CONCLUSIONS: Tiotropium resulted in a higher FEV(1) than placebo at 24 months and ameliorated the annual decline in the FEV(1) after bronchodilator use in patients with COPD of GOLD stage 1 or 2. (Funded by Boehringer Ingelheim and others; Tie-COPD ClinicalTrials.gov numbe …
CONCLUSIONS: Tiotropium resulted in a higher FEV(1) than placebo at 24 months and ameliorated the annual decline in the FEV(1) after broncho …